Eli Lilly & Co. has received approval from the Mexican regulatory authorities for Cialis, an oral PDE5 inhibitor for the treatment of erectile dysfunction.
The drug, which was developed through a collaboration between Eli Lilly and Icos Corporation, is now available in pharmacies by prescription in Mexico.
With the product introduction in Mexico, Cialis is now available in more than 40 countries on six continents. In the US, Cialis is currently under review by the FDA with Lilly Icos expecting a regulatory decision late in 2003.
"Mexico is one of the top ten world markets for ED therapies. There are an estimated five million Mexican men who suffer from erectile dysfunction and, with the regulatory approval of Cialis, they now have a new treatment option," said Edmundo Jimenez, director of marketing at Eli Lilly, Mexico.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment